Palvella Therapeutics Statistics
Total Valuation
PVLA has a market cap or net worth of $1.19 billion. The enterprise value is $1.14 billion.
| Market Cap | 1.19B |
| Enterprise Value | 1.14B |
Important Dates
The last earnings date was Tuesday, November 11, 2025, before market open.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PVLA has 11.84 million shares outstanding. The number of shares has increased by 60.51% in one year.
| Current Share Class | 11.84M |
| Shares Outstanding | 11.84M |
| Shares Change (YoY) | +60.51% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 16.76% |
| Owned by Institutions (%) | 54.44% |
| Float | 6.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 28.81 |
| P/TBV Ratio | 30.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.49, with a Debt / Equity ratio of 0.41.
| Current Ratio | 6.49 |
| Quick Ratio | 6.38 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.88 |
Financial Efficiency
Return on equity (ROE) is -301.19% and return on invested capital (ROIC) is -63.87%.
| Return on Equity (ROE) | -301.19% |
| Return on Assets (ROA) | -47.54% |
| Return on Invested Capital (ROIC) | -63.87% |
| Return on Capital Employed (ROCE) | -55.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.31M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 79.07 |
| 200-Day Moving Average | 43.74 |
| Relative Strength Index (RSI) | 63.94 |
| Average Volume (20 Days) | 258,353 |
Short Selling Information
The latest short interest is 680,117, so 5.75% of the outstanding shares have been sold short.
| Short Interest | 680,117 |
| Short Previous Month | 751,845 |
| Short % of Shares Out | 5.75% |
| Short % of Float | 10.33% |
| Short Ratio (days to cover) | 4.02 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -31.66M |
| Pretax Income | -32.95M |
| Net Income | -32.37M |
| EBITDA | n/a |
| EBIT | -31.66M |
| Earnings Per Share (EPS) | -$3.53 |
Balance Sheet
The company has $63.57 million in cash and $16.02 million in debt, giving a net cash position of $47.55 million or $4.02 per share.
| Cash & Cash Equivalents | 63.57M |
| Total Debt | 16.02M |
| Net Cash | 47.55M |
| Net Cash Per Share | $4.02 |
| Equity (Book Value) | 38.68M |
| Book Value Per Share | 3.49 |
| Working Capital | 56.63M |
Cash Flow
| Operating Cash Flow | -25.47M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PVLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.51% |
| Shareholder Yield | -60.51% |
| Earnings Yield | -2.72% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PVLA is $124.25, which is 23.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $124.25 |
| Price Target Difference | 23.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |